STALEY CAPITAL ADVISERS’s Genprex GNPX Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$11.5K	–	187
2023 Q4	$11.5K	Hold	1	–	–	﹤0.01%	178
2023 Q3	$19.7K	Hold	1	–	–	﹤0.01%	175
2023 Q2	$47.4K	Hold	1	–	–	﹤0.01%	181
2023 Q1	$45K	Hold	1	–	–	﹤0.01%	176
2022 Q4	$72K	Hold	1	–	–	﹤0.01%	165
2022 Q3	$70K	Hold	1	–	–	﹤0.01%	166
2022 Q2	$69K	Hold	1	–	–	﹤0.01%	166
2022 Q1	$113K	Hold	1	–	–	0.01%	177
2021 Q4	$66K	Hold	1	–	–	﹤0.01%	186
2021 Q3	$134K	Hold	1	–	–	0.01%	179
2021 Q2	$167K	Hold	1	–	–	0.01%	175
2021 Q1	$216K	Hold	1	–	–	0.01%	170
2020 Q4	$208K	Hold	1	–	–	0.01%	169
2020 Q3	$168K	Hold	1	–	–	0.01%	160
2020 Q2	$157K	Buy	+1	New	+$122K	0.01%	154

Other funds holding GNPX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

STALEY CAPITAL ADVISERS's GNPX Position: Q1 2024 in Review

STALEY CAPITAL ADVISERS sold out of Genprex (GNPX) in Q1 2024, closing a stake of 1 share — an estimated $11.5K sold.

STALEY CAPITAL ADVISERS first reported a position in GNPX in Q2 2020 and held it in 15 quarters. The position peaked at $216K in Q1 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

STALEY CAPITAL ADVISERS reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
STALEY CAPITAL ADVISERS sold 1 Genprex share in Q1 2024, an estimated $11.5K.
STALEY CAPITAL ADVISERS first reported a position in Genprex in Q2 2020 and held it in 15 quarters.
STALEY CAPITAL ADVISERS's Genprex position peaked at $216K in Q1 2021.
8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2024, filed 6 May 2024.